Shaun Rodriguez
Director/Miembro de la Junta en Multiply Labs, Inc. .
Perfil
Shaun Rodriguez has worked as a Director at Multiply Labs, Inc. and Exai Bio, Inc.
Cargos activos de Shaun Rodriguez
Empresas | Cargo | Inicio |
---|---|---|
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | Health Technology |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Technology Services |
- Bolsa de valores
- Insiders
- Shaun Rodriguez